AI assistant
C-RAD — Report Publication Announcement 2017
Oct 13, 2017
3148_rns_2017-10-13_41f20e95-1743-463a-b1bd-04140ea4efd7.pdf
Report Publication Announcement
Open in viewerOpens in your device viewer
Press release 2017-10-13
C-RAD Web Presentation Interim Report Q3 2017
Presentation of the report for the first three quarters of the fiscal year 2017:
Date: Friday October 27, 2017 / kl. 11:00 Venue: Online Presentation Topic: C-RAD Interim Report Q3 2017 Procedure: Please register online through the website: https://attendee.gotowebinar.com/register/5138153462507806466 After your registration, you will receive a confirmation via email.
A recording of the presentation will be made accessible on the C-RAD website after the presentation.
About C-RAD
C-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor localization and radiation treatment systems. All product development is conducted in three fully owned subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB, all of which are located in Uppsala, Sweden. C-RAD has established three companies for direct sales: C-RAD Inc. in the US, C-RAD GmbH in Germany and C-RAD WOFE in China. Cyrpa International SPRL, a Franco-Belgian laser company, is a wholly owned subsidiary whose operations are integrated. C-RAD AB is listed on NASDAQ Stockholm. For more information on C-RAD, please visit www.c-rad.com
For further information:
Tim Thurn, CEO C-RAD AB, Phone +46-18-666930, Email [email protected]